While most SIL1 mutation-positive MSS patients show the hallmark clinical features such as MR, myopathy, cerebellar atrophy and ataxia, and cataracts, additional features and their severity vary from patient to patient, seemingly depending on the mutation type at least to some extent. This evidence concerns the gene SIL1 and myopathy.